Phytoestrogens and the prevention of cancer

Functional Foods, Ageing and Degenerative Disease

Volumn , Issue , 2004, Pages 645-668

  Ungar, Y ^a   Shimoni, E ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875076706     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-85573-725-9.50027-7     Document Type: Chapter

References (176)

1. H ADLERCREUTZ (1990) ‘Western diet and western diseases: some hormonal and biochemical mechanisms and associations’. Scand J Clin Lab Invest. 50(suppl 201), 3-23
2. H ADLERCREUTZ (1998) ‘Evolution nutrition intestinalmicroflora and prevention of cancer: a hypothesis’. Proc Soc Exp Biol Med. 217 241-246
3. H ADLERCREUTZ (1998) Reproductive and development toxicology New York: Marcel Dekker Inc
4. H ADLERCREUTZ and W MAZUR (1997) ‘Phytoestrogens and western diseases’. Ann Med. 29 95-120
5. H C ADLERCREUTZ, G BANNWART, K WÄHÄLÄ, T MÄKELÄ, G BRUNOW, T HASE, P J AROSEMENA, J R KELLISJT and L E J VICKERY (1993) ‘Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens’. Steroid Biochem Mo Biol. 44 147-153
6. H C ADLERCREUTZ, B R GOLDIN and S L GORBACH (1995) ‘Soybean phytoestrogen intake and cancer risk’. J Nutr. 125 757S-770S
7. H ADLERCREUTZ, P BARTELS, V V ELOMAA and C KANG (2000) ‘Phytoestrogens and prostate cancer’. K Descheemaker, I Debruyne,(Eds) Soy and Health 2000: clinical evidence - dietetic applications Leuven/Apeldoorn: Garant 61-71
8. N AHMAD, D K FEYES, A L NIEMINEN, R AGARWAL and H MUKHTAR (1997) ‘Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cell’. J Natl Cancer Inst. 89 1881-1886
9. T AKIYAMA, J ISHIDA and S NAKAGAWA (1987) ‘Genistein, a specific inhibitor of tyrosine specific protein kinase’. J Biol Chem. 262 5592-5595
10. J J B ANDERSON (1999) ‘Plant-based diets and bone health: nutritional implications’. Am J Clin Nutr. 70 539S-542S
11. J J B ANDERSON and S C GARNER (1997) ‘The effects of phytoestrogens on bone’. Nutr Res. 17 1617-1632
12. J J ANDERSON and S C GARNER (1998) ‘Phytoestrogens and bone’. Baillieres Clinical Endocrinology and Metabolism 12 543-557
13. C AVIVI-GREEN, S POLAK-CHARCON, Z MADAR and B SCHWARTZ (2000) ‘Apoptosis cascade proteins are regulated in vivo by high intracolonic butyrate concentration: correlation with colon cancer inhibition’. Oncol Res. 12 83-95
14. BACH KNUDSEN K E, SERENA A, GLITSO V, ALDERCREUTZ H (2001), ‘Colonic formation and absorption of mammalian lignans and butyrate’, International Symposium on Whole Grain and Human Health, Porvoo, Finland
15. S BARNES, M KIRK and L COWARD (1994) ‘Isoflavones and their conjugates in soy foods: Extraction conditions and analysis by HPLCmass spectrometry’. J Agric Food Chem. 42(11), 2466-2474
16. A M BENSON, M J HUNKELER and P TALALAY (1980) ‘Increase of NAD(P)H: quinine reductase by dietary antioxidants possible role in protection against carcinogenesis and toxicity’. Proc Natl Acad Sci USA. 77 5216-5220
17. T W BOILEAU, S K CLINTON and J R ERDMANJW (2000) ‘Tissue concentration and isomer patterns are affected by androgen status and dietary lycopene concentration in male F344 rats’. J Nutr. 130 1613-1618
18. A BRZEZINSKI, H ADLERCREUTZ, R SHAOUL, A ROSLER, A SHMUELI, V TANOS and J G SCHENKER (1997) ‘Short-term effects of phytoestrogen-rich diet on postmenopausal women’. Menopause 4 89-94
19. B I CARLIN, T G PRETLOW, T P PRETLOW and M I RESNICK (1996) ‘Green tea polyphenols inhibit growth of prostate cancer chemoprevention’. Proc Am Assoc Cancer Res. 37 1915A
20. M C CARRAO-PANIZZI and K KITAMURA (1995) ‘Isoflavone content in Brazilian soybean cultivars’. Breeding Science. 45 295-300
21. L F CHASSEAUD (1979) ‘The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents’. Adv Cancer Res. 29 175-274
22. J S C CHOI, T W KWON and J S KIM (1996) ‘Isoflavone contents in some varieties of soybean’. Foods and Biotech. 5(2), 167-169
23. T B CLARKSON, M S ANTHONY and J R HUGHESCL (1995) ‘Estrogenic soybean isoflavones and chronic disease: risks and benefits’. Trends Endocrinol Metab. 6 11-16
24. W CLARK, A SANTOS-MOORE, L STEVENSON and J R FRACKELTONA (1996) ‘Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway’. Inter J Cancer. 65(2), 186-191
25. A H CONNEY, Z Y WANG, M T HUANG, Y R LOU and C S YANG (1995) ‘Inhibitory effects of green and black tea on carcinogenesis’. Proc Am Assoc Cancer Res. 36 704
26. A I CONSTANTINOU, R G MEHTA and A VAUGHAN (1996) ‘Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones’. Anticancer Res. 16 3293-3298
27. A I CONSTANTINOU, A E KRYGIER and R R MEHTA (1998) ‘Genistein induced maturation of cultured human breast cancer cells and prevents tumor growth in nude mice’. Am J Clin Nutr. 68 1426S-1430S
28. L COWARD, N BARNES, K D R SETCHELL and S BARNES (1993) ‘Genistein, Daidzein, and their β-glycoside conjugates: Antitumor isoflavones in soybean foods from American and Asian diets’. J Agric Food Chem. 41 1961-1967
29. L COWARD, M KIRK, N ALBIN and S BARNES (1996) ‘Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry’. Clinica Chimica Acta. 247(1-2), 121-142
30. L COWARD, M SMITH, M KIRK and S BARNES (1998) ‘Chemical modification of soy foods during cooking and processing’. Am J Clin Nutr. 68 1486S-1491S. (Suppl)
31. Q DAI, X O SHU, F JIN, J D POTTER, L H KUSHI, J TEAS, Y T GAO and W ZHENG (2001) ‘Population based case control study of soyfood intake and breast cancer risk in Shanghai’. Br J Cancer. 85 372-378
32. Q DAI, A A FRANKE, F JIN, X O SHU, J R HEBERT, L J CUSTER, J R CHENG, Y T GAO and W ZHENG (2002) ‘Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai’. Cancer Epidemiol Biomark Prev. 11 815-821
33. Q DAI, A A FRANKE, H YU, X O SHU, F JIN, J R HEBERT, L J CUSTER, Y T GAO and W ZHENG (2003) ‘Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics’. Cancer Epidemiol Biomark Prev. 12 497-502
34. F S DALAIS, G E RICE, M L WAHLQVIST, B H H HSUHAGE and N WATTANAPENPAIBOON (1998) ‘Urinary excretion of isoflavonoid phytoestrogens in Chinese and anglo Celtic population in Australia’. Nutr Res. 18 1703-1709
35. A DALU, J F HASKELL, L COWARD and C A LAMARTINIERE (1998) ‘Genistein a component of soy inhibits the expression of the EGF and Erb B2/Neu receptors in the rat dorsolateral prostate’. Prostate 37 36-43
36. M J DAVIES, E A BOWEY and H ADLERCREUTZ (1999) ‘Effects of soy or rye supplementation of high fat diets on colon tumor development in azoxymethane treated rats’. Carcinogenesis 20 927-931
37. S R DAVIS, A L MURKIES and G WILCOX (1998) ‘Phytoestrogens in clinical practice’. Integr Med. 1 27-34
38. J K DAY, M G HUFFORD, T R MCMANN, C BESCH-WILLIFORD, D B LUBAHN and R S MACDONALD (2001) Dietary genistein increased DMBA-induced mammary adenocarcinoma in ERαWT but not ERα KO mice’. Nutr Cancer. 39 226-232
39. W DEMARK-WAHNEFRIED, D T PRICE, T J POLASCIK, C N ROBERTSON, E E ANDERSON, D F PAULSON, P J WALTHER, M GANNON and R T VOLLMER (2001) ‘Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features’. Urology 58 47-52
40. I DEN TONKELAAR, L KEINAN-BOKER, P VAN'T VEER, C J M ARTS, H ADLERCREUTZ, J H H THIJSSEN and P H M PEETERS (2001) ‘Urinary phytoestrogens and postmenopausal breast cancer risk’. Cancer Epidemiol Biomarkers Prev. 10 223-228
41. J T DWYER, B R GOLDIN, N SAUL, L GUALTIERI, S BARAKAT and H ADLERCREUTZ (1994) ‘Tofu and soy drinks contain phytoestrogens’. J Am Diet Assoc. 94 739-743
42. B EISEN, Y UNGAR and E SHIMONI (2003) ‘Stability of isoflavones in soy milk stored at elevated and ambient temperatures’. J Agric Food Chem. 51 2212-2215
43. A EKBOM, D TRICHOPOULOS and H O ADMI (1992) ‘Evidence of prenatal influences on breast cancer risk’. Lancet 340 1015-1018
44. A C ELDRIDGE and W F KWOLEK (1983) ‘Soybean isoflavones: Effect of environment and variety on composition’. J Agric Food Chem. 31 394-396
45. L ERNSTER (1967) ‘DT diaphorase’. R W Estabrook, M E Pullman,(Eds) Methods in Enzymology New York: Academic Press 309-317
46. B A EVANS, K GRIFFITHS and M S MORTON (1995) ‘Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids’. J Endocrinol. 147 295-302
47. E FARMAKALIDIS and P A MURPHY (1985) ‘Isolation of 6”-O-Acetylgenistin and 6”-O-Acetyldaidzin from toasted defatted soyflakes’. J Agric Food Chem. 33 385-389
48. N R FARNSWORTH, A S BINGEL, G A CORDELL, F A CRANE and H H FONG (1975) ‘Potential value of plants as sources of new antifertility agents II’. J Pharm Sci. 64 717-754
49. D B FOURNIER, J R ERDMANJW and G B GORDON (1998) ‘Soy, its component, and cancer prevention: a review of the in vitro, animal, and human data’. Cancer Epidemiol Prev. 7 1055-1065
50. A A FRANKE, L J CUSTER, C.M. CERNA and K NARALA (1995) ‘Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine’. Proc Soc Exp Biol Med. 208 18-26
51. A A FRANKE, L J CUSTER, W WANG and C Y SHI (1998) ‘HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids’. Proc Soc Exp Biol Med. 217 263-273
52. W A FRITZ, L COWARD, J WANG and C A LAMARTINIERE (1998) ‘Dietary genistein: perinatal mammary cancer prevention bioavailability and toxicity testing in the rat’. Carcinogenesis 19 2151-2158
53. Y M FU, Z X YU, B A PELAYO, V J FERRANS and G G MEADOWS (1999) ‘Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency’. Cancer Res. 59 758-765
54. M FUKUTAKE, M TAKAHASHI, K ISHIDA, H KAWAMURA, T SUGIMURA and K WAKABAYASHI (1996) ‘Quantification of genistein and genistin in soybeans and soybean products’. Food and Chem Toxicol. 34(5), 457-461
55. GALLAHER D D, GALLAHER C M, HOFFMAN R M, (1996), ‘Soy protein isolate and genistein: effect on initiation and progression of colon cancer’, 2nd International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, Brussels, Belgium
56. R GARCIA-CLOSAS, A AGUDO, C A GONZALEZ and E RIBOLI (1998) ‘Intake of specific cartenoids and flavonoids and the risk of lung cancer in women in Barcelona’. Nutr Cancer. 32 154-158
57. G B GORDON, H J PROCHASKA and L Y S YANG (1991) ‘Induction of NAD(P)H: quinine reductase in human peripheral blood lymphocytes’. Carcinogenesis 12 2393-2396
58. T GOTOH, K YAMADA, H YIN, A ITO, T KATAOKA and K DOHI (1998) ‘Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A’. Jpn J Cancer Res. 89 137-142
59. S E HANKINSON, W C WILLETT, G A COLDITZ, D J HUNTER, D S MICHAUD, B DEROO, B ROSNER, F E SPEIZER and M POLLAK (1998) ‘Circulating concentrations of insulin-like growth factor-I and risk of breast cancer’. Lancet 351(9113), 1393-1396
60. HAYES S A, UNKLESBAY N, GRUN I, ‘Isoflavone stability in chocolate beverages’, 222nd ACS National Meeting, Chicago, IL, 2001
61. L HILAKIVI-CLARKE, E CHO and I ONOJAFE (1999) ‘Maternal exposure to genistein during pregnancy increases carcinogen induced mammary tumorigenesis in female rat offspring’. Oncol Rep. 6 1089-1095
62. K HIROSE, K TAJIMA, N HAMAJIMA, M INOUE, T TAKEZAKIE, M YOSHIDA and S TOKUDOME (1995) ‘A large scale hospital based case control study of risk factor of breast cancer according to menopausal status’. Jpn J Cancer Res. 86 146-154
63. M T HIROSE, C YAMAGUCHI and N LIN (2000) ‘Effects of arctiin on PhIP-induced mammary colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats’. Cancer Lett. 155 79-88
64. P L HORN-ROSS, E M JOHN, M LEE, S L STEWART, J KOO, L C SAKODA, A C SHIAU, J GOLDSTEIN, P DAVIS and E J PEREZ-STABLE (2001) ‘Phytoestrogens consumption and breast cancer risk in a multiethnic population’. Am J Epidemiol. 154(5), 434-441
65. C Y HSIEH, R C SANTELL, S Z HASLAM and W G HELFERICH (1998) ‘Estrogenic effects of genistein on the growth of estrogen receptor positive human breast cancer (MCF-7) cells in vitro and in vivo’. Cancer Res. 58 3833-3838
66. J HU, S ZHANG, E JIA, Q WANG, S LIU, Y LIU, Y WU and Y CHENG (1988) ‘Diet and cancer of the stomach: a case control study in China’. Int J Cancer. 41 331-335
67. A R IBRAHIM and Y J J ABUL-HAJJ (1990) ‘Aromatase inhibition by flavonoids’. Steroid Biochem Mol Biol. 37 257-260
68. D INGRAM, K SANDERS, M KOLYBABA and D LOPEZ (1997) ‘Case control study of phytostrogens and breast cancer’. Lancet 350 990-994
69. B K JACOBSEN, S F KNUTSEN and G E FRASER (1998) ‘Does high soy milk intake reduce prostate cancer incidence? The adventist health study’. Cancer Cause Control. 9 553-557
70. M G JAIN, G T HISLOP, G R HOWE and P GHADIRIAN (1999) ‘Plant foods, antioxidants and prostate cancer risk: findings from case control studies in Canada’. Nutr Cancer. 34 173-184
71. A E JONES, K R PRICE and G R FENWICK (1989) ‘Development and application of a high-performance liquid chromatographic method for the analysis of phytoestrogens’. J Sci Food Agric. 46 357-364
72. S KAWAII, Y TOMONO, E KATASE, K OGAWA and M YANO (1999) ‘Antiproliferative activity of flavonoids on several cancer cell lines’. Biosci Biotechnol Biochem. 63 896-899
73. J R KELLISJT and L E VICKEY (1984) ‘Inhibition of human estrogen synthetase (aromatase) by flavones’. Science 225 1032-1034
74. J R KELLISJT and L E VICKEY (1987) ‘The active site of aromatase cytochrome P-450. Differential effects of cyanide provide evidence for proximity of heme-iron and carbon-19 in the enzyme-substrate complex’. J Biol Chem. 262 8840-8844
75. J R KELLISJT, S NESNOW and L E VICKERY (1986) ‘Inhibition of aromatase cytochrome P-450 (estrogen synthetase) by derivatives of alpha-naphthoflavone’. Biochem Pharmac. 35 2887-2891
76. T J KEY, P N SHARP, P N APPLEBY, V BERAL, M T GOODMAN, M SODA and K MABUCHI (1999) ‘Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki Japan’. Br J Cancer. 81 1248-1256
77. A KILKKINEN, K STUMPF and P PIETINEN (2001) ‘Determinants of serum enterolactone concentration’. Am J Clin Nutr. 73 1094-1100
78. E KINOSHITA, T SUGIMOTO, Y OZAWA and T AISHIMA (1998) ‘Differentiation of soy sauce produced from whole soybeans and defatted soybeans by pattern recognition analysis of HPLC profiles’. J Agric Food Chem. 46 877-883
79. D L KLEINBERG (1998) ‘Role of IGF-I in normal mammary development’. Breast Cancer Res Treat. 47 201-208
80. P KNEKT, R JARVINEN, R SEPPANEN, M HELIOVAARA, L TEPPO, E PUKKALA and A AROMAA (1997) ‘Dietary flavonoids and the risk of lung cancer and other malignant neoplasms’. Am J Epidemiol. 146 223-230
81. P KNEKT, H ADLERCREUTZ and H RISSANEN (2000) ‘Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer?’. Br J Cancer. 82 1107-1110
82. L C KOO (1988) ‘Dietary habits and lung cancer risk among Chinese females in Hong Kong who never smoked’. Nutr Cancer. 11 155-172
83. S KUDOU, Y FLEURY, D WELTI, D MAGNOLATO, T UCHIDA, K KITAMURA and K OKUBO (1991) ‘Malonyl isoflavone glycosidesin soybean seeds (Glycine max merrill)’. Agric Biol Chem. 55 2227-2233
84. G G J M KUIPER, B CARLSSON, K GRANDIEN, E ENMARK, J HÄGGBLAD, S NILSSON and J GUSTAFSSON (1997) ‘Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and ß’. Endocrynology 138 863-870
85. S M KUO (1996) ‘Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells’. Cancer Lett. 110 41-48
86. M S KURZER and X XU (1997) ‘Dietary phytoestrogens’. Ann Rev Nutr. 17 353-381
87. E KYLE, L NECKERS, C TAKIMOTO, G CURT and R BERGAN (1997) ‘Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity’. Mol Pharmacol. 51 193-200
88. C A LAMARTINIERE (2000) ‘Protection against breast cancer with genistein: a component of soy’. Amer J Clin Nutr. 71 1705S-1707S
89. C A LAMARTINIERE, J B MOORE, N M BROWN, R THOMPSON, M J HARDIN and S BARNES (1995) ‘Genistein suppresses mammary cancer in rats’. Carcinogenesis 17 1451-1457
90. J C LE BAIL, F VARNAT, J C NICOLAS and G HABRIOUX (1998) ‘Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids’. Cancer Lett. 130 209-216
91. H P LEE, L GOURLEY, S W DUFFY, J ESTEVE, J LEE and N E DAY (1991) ‘Dietary effects on breast cancer risk in Singapore’. Lancet 337 1197-1200
92. S J LEE, J K AHN, S H KIM, J T KIM, S J HAN, M Y JUNG and I M CHUNG (2003) ‘Variation in isoflavones of soybean cultivars with location and storage duration’. J Agric Food Chem. 51 3382-3389
93. D H LI, J A YEE, M H MCGUIRE, P A MURPHY and L YAN (1999) ‘Soybean isoflavones reduce experimental metastasis in mice’. J Nutr. 129 1075-1078
94. S LIAO, Y UMEKITA, J GOU, J M KOKONTIS and R A HIIPAKKA (1995) ‘Growth inhibition and regression of human prostate and breast tumors in athymic mice by epigallocatechin gallate’. Cancer Lett. 96 239-243
95. F R LIAN, M BHUIYAN, Y W LI, N WALL, M KRAUT and F H SARKAR (1998) ‘Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung, cancer cell line’. Nutr Cancer. 31 184-191
96. A H LICHTENSTEIN (1998) ‘Soy protein, isoflavones and cardiovascular disease risk’. J Nutr. 128 1589-1592
97. L W LU, L D BROEMELING, M V MARSHALL and S RAMANUJAM (1995) ‘A simplified method to quantify isoflavones in commercial soybean diets and human urine after legume consumption’. Cancer Epidemiol Biomark Prevention 4 497-503
98. L W LU, J J GRADY, M V MARSHALL, V M S RAMANUJAM and K E ANDERSON (1995) ‘Altered time course of urinary daidzein and genistein excretion during chronic soya diet in healthy males’. Nutr Cancer. 24 311-323
99. S M MAHUNGU, S DIAZ-MERCADO, J LI, M SCHWENK, K SINGELTARY and J FALLER (1999) ‘Stability of isoflavones during extrusion processing of corn/soy mixture’. J Agric Food Chem. 47 279-284
100. G MASKARINEC, S SINGH, L X MENG and A A FRANKE (1998) ‘Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population’. Cancer Epidemiol. Biomarker Prev. 7 613-619
101. Y MATSUKAWA, N MARUI, T SAKAI, Y SATOMI, M YOSHIDA, K MATSUMOTO, H NISHINO and A AOIKE (1993) ‘Genistein arrests cell cycle progression at G2-M’. Cancer Res. 53 1328-1331
102. W MAZUR, T FOTSIS, K WAHALA, S OJALA, A SALAKKA and H ADLERCREUTZ (1996) ‘Isotope dilution gas chromatographic-mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples’. Anal Biochem. 233(2), 169-180
103. W M MAZUR, J A DUKE, K WAHALA, S RASKU and H ADLERCREUTZ (1998) ‘Isoflavonoids and lignans in legumes: Nutritional and health aspects in humans’. Nutritional Biochem. 9 193-200
104. M MESSINA and C L LOPRINZI (2001) ‘Soy for breast cancer survivors: a critical review of the literature’. J Nutr. 131 3095S-3108S
105. R J MIKSICEK (1995) ‘Estrogenic flavonoids: structural requirements for biological activity’. Proc Soc Exp Biol Med. 201 44-50
106. M S MORTON, P S CHAN, N BLACKLOCK, A MATOS-FERREIRA, L ABRANCHES-MONTEIRO, R CORREIA, S LLOYD and K GRIFFITHS (1997) ‘Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom’. Prostate 32(2), 122-128
107. G R MOULE, A W H BRADEN and D R LAMOND (1963) ‘The significance of oestrogens in pasture plants in relation to animal production’. Anim Breeding Abstr. 31 139-157
108. A MURKIES, F S DALAIS, E M BRIGANTI, H G BURGER, D L HEALY, M L WAHLQVIST and S R DAVIES (2000) ‘Phytoestrogens and breast cancer in postmenopausal women: a case control study’. Menopause 7 289-296
109. P A MURPHY, T SONG, G BUSEMAN and K BARUA (1997) ‘Isoflavones in soy-based infant formulas’. J Agric Food Chem. 45 4635-4638
110. P A MURPHY, T SONG, G BUSEMAN, K BARUA, G R BEECHER, D TRAINER and J HOLDEN (1999) ‘Isoflavones in retail and institutional soy foods’. J Agric Food Chem. 47 2697-2704
111. M MUTANEN, A M PAJARI and S I OIKARINEN (2000) ‘Beef induced and rye bran prevents the formation of intestinal polyps in ApcMic mice: relation to β-catenin and PKC isozymes’. Carcinogenesis 21 1167-1173
112. H R NAIK, J E LEHR and K J PIENTA (1994) ‘An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer’. Anticancer Res. 14 2617-2620
113. M NAIM, B GESTETNER, S ZILKAH, Y BIRK and A BONDI (1976) ‘Soybean isoflavones, characterization, determination, and antifungal activity’. J Agric Food Chem. 22 806-810
114. T NGUYENLE, E WANG and A P CHEUNG (1995) ‘An investigation on the extraction and concentration of isoflavones in soy-based products’. J Phamaceut Biomed Analysis 14 221-232
115. W A NIJHOFF, G M GROEN and W H M PETERS (1993) ‘Induction of rat hepatic and intestinal glutathione S-transferases and glutathione by dietary naturally occurring anticarcinogens’. Int J Oncol. 3 1131-1139
116. J E OESTERLING, Y KUMAMOTO and T TSUKAMOTO (1995) ‘Serum prostate specific antigen in a community based population of healthy Japanese men: lower value than for similarly aged white men’. Br J Urol. 75 347-353
117. T OHTA, S NAKATSUGI, K WATANABE, T KAWAMORI, F ISHIKAWA, M MOROTOMI, S SUGIE, T TODA, T SUGIMURA and K WAKABAYASHI (2000) ‘Inhibitory effects of bifidobacterium fermented soymilk on 2-amino-methyl-6-phenylimidazo4, 5-bpyridine-induced rat mammary carcinogenesis, with a partial contribution of its component isoflavones’. Carcinogenesis 21 937-941
118. M ONOZAWA, T KAWAMORI, M BABA, K FUKUDA, T TODA, H SATO, M OHTANI, H AKAZA, T SUGIMURA and K WAKABAYASHI (1999) ‘Effects of a soybean isoflavone mixture on carcinogenesis in prostate and seminal vesicles of F344 rats’. Jpn J Cancer Res. 90 393-398
119. S R PADGETTE, N B TAYLOR, D L NIDA, M R BAILEY, J MACDONALD, L R HOLDEN and R L FUCHS (1996) ‘The composition of glyphosate-tolerant soybean seeds is equivalent to that of conventional soybeans’. J Nutr. 126(3), 702-716
120. M A PEREIRA, L H BARNES, V L RASSMAN, G V KELLOFF and V E STEELE (1994) ‘Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents’. Carcinogenesis 15 1049-1054
121. G PETERSON and S BARNES (1991) ‘Genistein inhibition of the growth of human breast cancer cell independence from estrogen receptors and the multidrug resistance gene’. Biochem Biophys Res Commun. 179 661-667
122. T G PETERSON, L COWARD and M KIRK (1996) ‘The role of metabolism in mammary epithelial cell growth inhibition by the isoflavones genistein and biochanin A’. Carcinogenesis 17 1861-1869
123. H PETTERSON and K H KIESSLING (1984) ‘Liquid chromatographic determination of the plant estrogens coumestrol and isoflavones in animal feed’. J Assoc Off Ana. Chem. 67(3), 503-506
124. J P PEYRAT, J BONNETERRE, B HECQUET, P VENNIN, M M LOUCHEZ, C FOURNIER, J LEFEBVRE and A DEMAILLE (1993) ‘Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer’. Eur J Cancer. 29a(4), 492-497
125. M PIANTELLI, A RINELLI, E MACRI, N MAGGIANO, L M LAROCCA, M SCERRATI, R ROSELLI, M IACOANGELI, G SCAMBIA, A CAPELLI and F O RANELLETTI (1993) ‘Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas’. Cancer 71 193-198
126. P PIETINEN, K STUMPF and S MANNISTO (2001) ‘Serum enterolactone and risk of breast cancer: a case control study in eastern Finland’. Cancer Epidem Biomark Prev. 70 339-344. 2001
127. A C W PIKE, A M BRZOZOWSKI, R E HUBBARD, T BONN, A G THORSELL, O ENGSTRÖM, J LJUNGGREN, J A GUSTAFSSON and M CARLQUIST (1999) ‘Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist’. EMBO J. 18 4608-4618
128. M N POLLAK, H T HUYNH and S P LEFEBVRE (1992) ‘Direct effects of tamoxifen on growth hormone secretion by pituitary cells in vitro’. Breast Cancer Res Treat. 22 91-100
129. M POLLARD and P H LUCKERT (1997) ‘Influence of isoflavones in soy protein isolates on development of induced prostate related cancer in L-W rats’. Nutr Cancer. 28 41-45
130. D E PRATT and P M BIRAC (1979) ‘Source of antioxidant activity of soybeans and soy products’. J Food Sci. 44 1720-1722
131. S E RICKARD, Y V YUAN, J CHEN and L U THOMPSON (1999) ‘Dose effects of flaxseed and its lignan on N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats’. Nutr Cancer. 35 50-57
132. S E RICKARD, Y V YUAN and L U THOMPSON (2000) ‘Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside’. Cancer Lett. 161 47-55
133. E H RODGERS and M H GRANT (1998) ‘The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF7 human breast cancer cells’. Chem Biol Interact 116 213-228
134. M B RUIZ-LARREA, A R MOHAN and G PAGANGA (1987) ‘Antioxidant activity of phytoestrogenic isoflavones’. Free Radical Res. 26 63-70
135. E M SCHOLAR and M L TOEWS (1994) ‘Inhibition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein’. Cancer Lett. 87 159-162
136. A SEO and C V MORR (1984) ‘Improved high-performance liquid chromatographic analysis of phenolic acids and isoflavonoids from soybean protein products’. J Agric Food Chem. 32 530-533
137. M SERRAINO and L U THOMPSON (1991) ‘The effect of flaxseed supplementation on early risk markers for mammary carcinogenesis’. Cancer Lett. 60(2), 135-142
138. M SERRAINO and L U THOMPSON (1992) ‘The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis’. Nutr Cancer. 17 153-159
139. K D R SETCHELL (1998) ‘Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones’. Am J Clin Nutr. 68 1333S-1346S. (Suppl)
140. K D R SETCHELL and B WELSHM (1987) ‘High-performance liquid chromatographic analysis of phytoestrogens in soy protein preparations with ultraviolet, electrochemical and thermospray mass spectrometric detection’. J Chromatography 386 315-323
141. K D R SETCHELL, L ZIMMER-NECHEMIAS, J CAI and J E HEUBI (1997) ‘Exposure of infants to phyto-oestrogens from soy-based infant formula’. Lancet 350 23-27
142. R K SEVERSON, A M NOMURA, J S GROVE and G N STEMMERANN (1989) ‘A prospective study of semographics diet and prostate cancer among men of Japanese ancestry in Hawaii’. Cancer Res. 49 1857-1860
143. X O SHU, F JIN, Q DAI, W WEN, J D POTTER, L H KUSHI, Z RUAN, Y T GAO and W ZHENG (2001) ‘Soyfood intake during adolescence and subsequently risk of breast cancer among Chinese women’. Cancer Epidemiol Biomarkers Prev. 10 483-488
144. D A SHUTT and R I COX (1972) ‘Steroid and phyto-estrogen binding to sheep uterine receptors in vitro’. J Endocrinol. 52 299-310
145. K SINGLETARY, J FALLER, J Y LI and S MAHUNGU (2000) ‘Effect of extrusion on isoflavone content and antiproliferative bioactivity of soy/corn mixtures’. J Agric Food Chem. 48 3566-3571
146. F V SO, N GUTHRIE, A F CHAMBERS, M MOUSSA and K K CARROLL (1996) ‘Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices’. Nutr Cancer. 26 167-181
147. F V SO, N GUTHRIE, A F CHAMBERS and K K CARROLL (1997) ‘Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen’. Cancer Lett. 112 127-133
148. F SPINOZZI, M C PAGLIACCI, G MIGLIOATI, R MORACA, F GRIGNANI, C RICCARDI and I NICOLETTI (1994) ‘The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jukat T-leukemia cells’. Leuk Res. 18 431-439
149. P TALALAY (1989) ‘Mechanisms of induction of enzymes that protect against chemical carcinogenesis’. Adv Enzyme Regul. 28 237-250
150. P TALALAY, J W FAHEY, W D HOLTZCLAW, T PRESTERA and Y ZHANG (1995) ‘Chemoprotection against cancer by phase 2 enzyme induction’. Toxicol Lett. 82-83 173-179
151. D G THIAGARAJAN, M R BENNINK, L D BOURQUIN and F A KAVAS (1998) ‘Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium’. Am J Clin Nutr. 68 1394S-1399S
152. L U THOMPSON, M M SEIDL, S E RICKARD, L J ORCHESON and H H FONG (1996) Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr Cancer. 26 159-165
153. L U THOMPSON, S E RICKARD and L ORCHESON SEIDL (1996) ‘Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis’. Carcinogenesis 17 1373-1376
154. J C L TOU and L U THOMPSON (1999) ‘Exposure to flaxseed or its lignan component during different development stages influences rat mammary gland structure’. Carcinogenesis 20 1831-1835
155. F TRAGANOS, B ARDELT, N HALKO, S BRUNO and Z DARZYNKIEWICZ (1992) ‘Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells’. Cancer Res. 52 6200-6208
156. Y UNGAR, O F OSUNDAHUNSI and E SHIMONI (2003) ‘Thermal stability of genistein and daidzein and its effect on their antioxidant activity’. J Agric Food Chem. 51 4394-4399
157. S P VERNA, E SALAMONE and B GOLDIN (1997) ‘Curcumine and genistein plant natural products show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides’. Biochem Biophys Res Commun. 233 692-696
158. S P VERNA and B R GOLDIN (1998) ‘Effect of soy derived isoflavonoids on the induced growth of MCF-7 cells by estrogenic environmental chemicals’. Nutr Cancer. 30 232-239
159. W WANG and C M HIGUCHI (2000) ‘Dietary soy protein is associated with reduced intestinal mucosal polyamine concentration in male Wistar rats’. J Nutr. 130 1815-1820
160. C WANG and M S KURZER (1997) ‘Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells’. Nutr Cancer. 28(3), 236-247
161. H WANG and P A MURPHY (1994) ‘Isoflavone composition of American and Japanese soybeans in Iowa: effects of variety, crop year, and location’. J Agric Food Chem. 42 1674-1677
162. H WANG and P A MURPHY (1994) ‘Isoflavone content in commercial soybean foods’. J Agric Food Chem. 42 1666-1673
163. H J WANG and P A MURPHY (1996) ‘Mass balance study of isoflavones during soybean processing’. J Agric Food Chem. 44 2377-2383
164. G WANG, S S KUAN, O J FRANCIS, G M WARE and A S CARMAN (1990) ‘Simplified HPLC method for the determination of phytoestrogens in soybean and its processed products’. J Agric Food Chem. 38 185-190
165. C WANG, T MÄKELÄ, T HASE, H ADLERCREUTZ and M S KURZER (1994) ‘Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes’. J Steroid Biochem Mol Biol. 50 205-212
166. T T WANG, N SATHYAMOORTHY and J M PHANG (1996) ‘Molecular effects of genistein on estrogen receptor mediated pathways’. Carcinogenesis 17 271-275
167. C WANG, Q MA, S PAGADALA, M S SHERRARD and P G KIRSHNAN (1998) ‘Changes of isoflavones during processing of soy protein isolates’. J Am Oil Chem Soc. 75 337-341
168. W WANG, L Q LIU, C M HIGUCHI and H CHEN (1998) ‘Induction of NADPH:quinone reductase by dietary phytoestrogens in colonic Colo205 cells’. Biochem Pharmacol. 56 189-195
169. H C WEI, R BOWEN, X S ZHANG and M LEBWOHL (1998) ‘Isoflavone genistein inhibits the intiation and promotion of two stage skin carcinogenesis in mice’. Carcinogenesis 19 1509-1514
170. A H WU, R G ZIEGLER, P L HORN-ROSS, D W WEST, L N KOLONEL and J F ROSENTHAL (1996) ‘Tofu and risk of breast cancer in Asian-American’. Cancer Epidemiol Biomark Prev. 5 901-906
171. Z XU, Q WU and S J GODBER (2002) ‘Stabilities of daidzin, glycitin, genistin, and generation of derivatives during heating’. J Agric Food Chem. 50 7402-7406
172. H YOKOSHIKI, K SUMII and N SPERELAKIS (1996) ‘Inhibition of L-type calcium current in rat ventricular cells by the tyrosine kinase inhibitor genistein and its inactive analog daidzein’. J Mol Cell Cardiol. 28 807-814
173. D T ZAVA and G DUWE (1997) ‘Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro’. Nutr Cancer. 27 31-40
174. J X ZHANG, G HALLMANS, M LANDSTROM, A BERGH, J E DAMBER, P AMAN and H ADLERCREUTZ (1997) ‘Soy and rye diets inhibit the development of Dunning R3327 rostatic adenocarcinoma in rats’. Cancer Lett. 114 313-314
175. W ZHENG, Q DAI, L J CUSTER, X O SHU, W Q WEN, F JIN and A A FRANKE (1999) ‘Urinary excretion of isoflavonoids and the risk of breast cancer’. Cancer Epidemiol Biomarkers Prev. 8 35-40
176. J R ZHOU, P MUKHERJEE, E T GUGGER, T TANAKA, G L BLACKBUM and S K CLINTON (1998) ‘Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis’. Cancer Res. 58 523-538